Compared to previous studies, this research presented more detailed and robust experimental evidence, demonstrating the effectiveness and safety of TMTP1-TSRP-EVs in inhibiting bone metastasis in PI3K-mutant NSCLC [50, 80, 81]. Here, PIK3CA is linked to non-small cell lung carcinoma.